FORMULATION, CHARACTERIZATION AND OPTIMIZATION OF PLGA-CHITOSAN LOADED FATTYACID SCAFFOLDS FOR THE TREATMENT OF DIABETIC WOUNDS

SHILPA.N. THUMBOORU; SYED SUHAIB AHMED; BALAJI HARI; GOWRAV MP; KARRI VVS NARAYANA REDDY

doi:10.22159/ijap.2024v16i6.51509

Authors

SHILPA.N. THUMBOORU Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Nilgiris, Tamil Nadu, India https://orcid.org/0000-0003-1268-481X
SYED SUHAIB AHMED Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, Tamil Nadu, India https://orcid.org/0000-0002-0290-2003
BALAJI HARI Department of Pharmacognosy, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Nilgiris, Tamil Nadu, India https://orcid.org/0000-0002-4557-6703
GOWRAV MP Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India https://orcid.org/0000-0001-6621-4392
KARRI VVS NARAYANA REDDY Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Nilgiris, Tamil Nadu, India https://orcid.org/0000-0003-2057-3423

DOI:

https://doi.org/10.22159/ijap.2024v16i6.51509

Keywords:

PUFAs, Chitosan, Scaffolds, PLGA, Diabetes, Wounds, In vitro drug release, In vitro studies

Abstract

Objective: The objective of the current research to formulate Eicosapentanoic Acid/Decosahexanoic Acid (EPA/DHA)incorporated into Chitosan (CS)and Poly-Lactic -Glycolic Acid (PLGA), nanoparticles composite scaffolds to the accelerated diabetic wound healing.The main focus of this present research is to evaluate and develop the chitosan –PLGA biodegradable polymer scaffolds loaded with long chain omega-3 Polyunsaturated Fatty Acids (PUFA’s) (EPA/DHA).

Methods: Nano scaffolds were prepared by solvent evaporation method loaded with CS-PLGA, EPA and DHA to treat diabetic wounds at targeted site as pharmacotherapeutically. Upon investigation, the developed biodegradable crosslinked scaffold possesses matrix degradation, optimal porosity, prolonged drug release action than the non-cross linked scaffold. The prepared formulation containing CS-PLGA loaded with EPA/DHA were formulated as nanoscaffold for wound topical applications was carried out by using freeze drying process.

Results: The prepared CS-PLGA nano scaffolds were optimized and evaluated for physicochemical properties, dynamic light scattering with a particle size of 248 nm and zeta of -24mVand Scanning Electron Microscopy (SEM) were found to be spherical. In addition, the optical properties of EPA/DHA and PLGA, along with CS, can be compared by examining their absorption and wavelength (nm) using UV-Visible spectroscopy. The structural and functional groups of the prepared end products were characterized by Fourier- Transformed Infrared Spectroscopy (FT-IR) has shown good compatibility with excipients and nanoformulaton, in-vitro drug release studies done by using dialysis bag membrane results find that first order Higuchi model was followed showing 20% release in first 0.2 hr. MTT(3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide) assay was carried out and it showed that both crosslinked and non-crosslinked scaffolds(110 and 120%) improved cell growth when compared to control (100%).

Conclusion: Finally, the results showed that the PLGA, CS nanoscaffolds containing 98% of PUFA’s (EPA/DHA) have increased in proinflammatory cytokines production at the particular wound site and thus accelerated healing activity, depending on the pre-clinical studies have trespassed, the therapeutic potential to penetrating at wound site. The optimized nanoformulation could be a better formulation for targeting and treatment of diabetic wounds at an optimal ratio.

Downloads

Download data is not yet available.

References

Williams R, Karuranga S, Malanda B, Saeedi P, Basit A, Besançon S, Bommer C, Esteghamati A, Ogurtsova K, Zhang P, Colagiuri S. Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice. 2020 Apr 1;162:108072. doi:10.1016/j.diabres.2020.108072.

Siersma V, Thorsen H, Holstein PE, Kars M, Apelqvist J, Jude EB, Piaggesi A, Bakker K, Edmonds M, Jirkovska A. Health-related quality of life predicts major amputation and death, but not healing, in people with diabetes presenting with foot ulcers: the Eurodiale study. Diabetes Care. 2014;37(3):694–700. doi: 10.2337/dc13-1212.

Morimoto M, Lee EY, Zhang X, Inaba Y, Inoue H, Ogawa M, Shirasawa T, Yokosuka O, Miki T. Eicosapentaenoic acid ameliorates hyperglycemia in high-fat diet-sensitive diabetes mice in conjunction with restoration of hypoadiponectinemia. Nutrition & Diabetes. 2016;6(6):e213–e213. doi: 10.1038/nutd.2016.21.

Qin L, Mei Y, An C, Ning R, Zhang H. Docosahexaenoic acid administration improves diabetes-induced cardiac fibrosis through enhancing fatty acid oxidation in cardiac fibroblast. The Journal of Nutritional Biochemistry. 2023;113:109244. doi: 10.1016/j.jnutbio.2022.109244.

Panda BP, Krishnamoorthy R, Bhattamisra SK, Shivashekaregowda NKH, Seng LB, Patnaik S. Fabrication of second generation smarter PLGA based nanocrystal carriers for improvement of drug delivery and therapeutic efficacy of gliclazide in type-2 diabetes rat model. Scientific reports. 2019;9(1):17331. doi: 10.1038/s41598-019-53996-4.

Panda BP, Krishnamoorthy R, Shivashekaregowda NKH, Patnaik S. Influence of Poloxamer-188 on design and development of second generation PLGA nanocrystals of metformin hydrochloride. Nano Biomed Eng. 2018;10(4):334–43. doi: 10.5101/nbe.v10i4.p334-343.

Sanapalli BKR, Yele V, Singh MK, Thumbooru SN, Parvathaneni M, Karri VVSR. Human beta defensin-2 loaded PLGA nanoparticles impregnated in collagen-chitosan composite scaffold for the management of diabetic wounds. Biomedicine & Pharmacotherapy. 2023;161:114540. doi: 10.1016/j.biopha.2023.114540.

Ahmed SS, Baqi MA, Baba MZ, Jawahar N. Formulation, characterization and optimization of folic acid-tailored daidzein solid lipid nanoparticles for the improved cytotoxicity against colon cancer cells. International Journal of Applied Pharmaceutics. 2024 Mar 7;320–8. doi: 10.22159/ijap.2024v16i2.49879.

Natarajan J, Sanapalli BKR, Bano M, Singh SK, Gulati M, Karri VVSR. Nanostructured Lipid Carriers of Pioglitazone Loaded Collagen/Chitosan Composite Scaffold for Diabetic Wound Healing. Advances in Wound Care. 2019 Oct 1;8(10):499–513. doi: 10.1089/wound.2018.0831.

Mat Saad AZ, Khoo TL, Halim AS. Wound bed preparation for chronic diabetic foot ulcers. International Scholarly Research Notices. 2013;2013(1):608313.

Ahmed SS, Sriramcharan P, Arivuselam R, Raman R, Venkatachalam S, Natarajan J. Green synthesis of bovine serum albumin–tailored silver nanoparticles from ASPERGILLUS FUMIGATUS : Statistical optimization, characterization, antioxidant, and cytotoxicity evaluation on colon cancer cells. Applied Organom Chemis. 2024 Apr;38(4):e7386. doi: 10.1002/aoc.7386.

Hu X, He J, Qiao L, Wang C, Wang Y, Yu R, Xu W, Wang F, Yang S, Zhang X, Qian Z. Multifunctional Dual Network Hydrogel Loaded with Novel Tea Polyphenol Magnesium Nanoparticles Accelerates Wound Repair of MRSA Infected Diabetes. Adv Funct Materials. 2024 Feb 6;2312140. doi: 10.1002/adfm.202312140.

Sharma A, Mehta V, Parashar A, Patrwal R, Malairaman U. Solid lipid nanoparticle: fabricated through nanoprecipitation and their physicochemical characterization. Int J Pharm Pharm Sci. 2016 Aug 12;8(10):144. doi: 10.22159/ijpps.2016v8i10.13207.

Varma R, Vasudevan S. Extraction, Characterization, and Antimicrobial Activity of Chitosan from Horse Mussel Modiolus modiolus. ACS Omega. 2020 Aug 18;5(32):20224–30. doi: 10.1021/acsomega.0c01903.

Mahalingam M, Krishnamoorthy K. Camptothecin loaded poly (methacyclic acid-co-methyl-methyacrylate) nanoparticles: Fabrication, characterization and cytotoxicity studies. Int J Pharm Pharm Sci. 2015;7(10):135–40.

Chen Y, Zhao W, Dai H. Porous PLGA-PEG nerve conduit decorated with oriented electrospun chitosan-RGD nanofibre. Journal of Materials Research and Technology. 2021 Nov 1;15:86–98. doi: 10.1016/j.jmrt.2021.07.117.

do Amaral Montanheiro TL, Montagna LS, Patrulea V, Jordan O, Borchard G, Ribas RG, Campos TMB, Thim GP, Lemes AP. Enhanced water uptake of PHBV scaffolds with functionalized cellulose nanocrystals. Polymer Testing. 2019;79:106079. doi: 10.1016/j.polymertesting.2019.106079.

Rajput IB, Tareen FK, Khan AU, Ahmed N, Khan MFA, Shah KU, Rahdar A, Díez-Pascual AM. Fabrication and in vitro evaluation of chitosan-gelatin based aceclofenac loaded scaffold. International Journal of Biological Macromolecules. 2023;224:223–32. doi: 10.1016/j.ijbiomac.2022.10.118.

Intini C, Elviri L, Cabral J, Mros S, Bergonzi C, Bianchera A, Flammini L, Govoni P, Barocelli E, Bettini R. 3D-printed chitosan-based scaffolds: An in vitro study of human skin cell growth and an in-vivo wound healing evaluation in experimental diabetes in rats. Carbohydrate polymers. 2018;199:593–602. doi: 10.1016/j.carbpol.2018.07.057.

Jahangir MA, Khan R, Sarim Imam S. Formulation of sitagliptin-loaded oral polymeric nano scaffold: process parameters evaluation and enhanced anti-diabetic performance. Artificial Cells, Nanomedicine, and Biotechnology. 2018 Oct 31;46(sup1):66–78. doi: 10.1080/21691401.2017.1411933.

Khazaeli P, Alaei M, Khaksarihadad M, Ranjbar M. Preparation of PLA/chitosan nanoscaffolds containing cod liver oil and experimental diabetic wound healing in male rats study. J Nanobiotechnol. 2020 Dec;18(1):176. doi: 0.1186/s12951-020-00737-9.

Bhardwaj A, Modi KP. Antidiabetic and antihyperlipidaemic activity of nelumbo nucifera gaertn ethanol seed extract in streptozotocin induced diabetic rats. International Journal of Pharmacy and Pharmaceutical Sciences Innovare Academic Sciences Pvt Ltd. 2017;9(10):197. doi: 10.22159/ijpps.2017v9i10.21455.

Anitha R, Vaikkath D, Shenoy SJ, Nair PD. Tissue‐engineered islet‐like cell clusters generated from adipose tissue‐derived stem cells on three‐dimensional electrospun scaffolds can reverse diabetes in an experimental rat model and the role of porosity of scaffolds on cluster differentiation. J Biomedical Materials Res. 2020 Mar;108(3):749–59. doi: 0.1002/jbm.a.36854.